JPRN-UMIN000009604已完成未知
Assessment of QUAlity of life during long-term treatment of ToLVapatan in refractory heart failure.(AQUA-TLV) - Assessment of QUAlity of life during long-term treatment of ToLVapatan in refractory heart failure.(AQUA-TLV)
niversity of Tokyo Hospital0 个研究点目标入组 28 人开始时间: 2012年12月21日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 28
研究概览
简要总结
Tolvaptan arm had significantly improved quality of life compared with the control arm
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) serum sodium concentration over 145mEq/L 2) patients who were administered tolvaptan before admission 3) patients who had received mechanical devices 4) patients with acute coronary syndrome 5) patients with future surgical procedure 6) patients with anuria 7) patients unable to drink 8) patients unable to take medicine orally 9) patients with urine osmolality under 350 mOsm/
研究者
相似试验
已完成
不适用
Health-related QoL Following TAVI TAo, TAVI TF and AVRQuality of LifeNCT03583398Medical University of Gdansk97
已完成
不适用
Home Visit Intervention in Pediatric Palliative CarePediatric CancerPalliativeNCT04067687Indonesia University60
终止
4 期
QoL-Comparison Between Trabectedin/PLD and Pt-based Therapy in Patients With Pt-sensitive Recurrent Ovarian CancerQuality of LifeRecurrent Ovarian CarcinomaOvarian CancerNCT03164980North Eastern German Society of Gynaecological Oncology89
撤回
不适用
Quality of Life Following ECMOExtracorporeal Membrane OxygenationQuality of LifeNCT02809703Duke University
已完成
不适用
Clinical Safety and Effectiveness of Tolvaptan for patients with heart falureheart failureJPRN-UMIN000031667Teikyo University317